GE Healthcare and CorTechs Labs have just announced the signing of a strategic joint-marketing agreement, whereby the companies will collaborate to co-market powerful MRI scanning solutions combined with NeuroQuant, MRI post-processing application from CorTechs Labs. NeuroQuant enables the acquisition of volumetric brain image data and automatically conducts accurate and consistent measurements of cortical and subcortical volumes targeted at identifying evidence of neurodegeneration. This provides neurologists and radiologists with objective support for clinical analysis. “Accurate measurement of volumes of different parts of the brain may be a useful aid in the diagnosis of neurodegenerative diseases such as Alzheimer’s, multiple sclerosis and traumatic brain injury,” says Chris Airriess, CTO of , CorTechs Labs. “In the literature volume changes in certain brain structures have been linked to early indications of such conditions where more traditional diagnoses lack detection sensitivity.” NeuroQuant does this in an automated fashion and with no user intervention,
Cortechs Labs,
San Diego, CA, USA